These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 525724)

  • 1. [Treatment of spontaneous abortions with the preparation, Provera].
    Despodova D; Georgieva M; Katsarova M
    Akush Ginekol (Sofiia); 1979; 18(6):457-61. PubMed ID: 525724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Magnesium sulfate treatment of threatened late abortions and premature labor].
    Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D
    Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term results of treatment with a delayed-action progestational hormone in threatened abortion].
    Scillieri P
    Minerva Ginecol; 1970 Apr; 22(7):413-6. PubMed ID: 5510032
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the use of a delayed-action progestational hormone in threatened abortion].
    Candotti G; Scillieri P
    Minerva Ginecol; 1968 Jul; 20(13):1147-51. PubMed ID: 5706588
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of habitual abortion with caprovestrol].
    Kovtumova LG; Turbina ZV; Rymashevskaia EP; Zelenkova LT
    Vopr Okhr Materin Det; 1976 May; 21(5):72-5. PubMed ID: 1027289
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysfunctional bleeding subsequent to progestin therapy.
    Luby RJ
    Obstet Gynecol; 1965 Oct; 26(4):467-9. PubMed ID: 5294149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gynecological indications of a new progestational agent with prolonged action].
    Goisis M; Candotti G
    Minerva Ginecol; 1970 Mar; 22(6):339-67. PubMed ID: 5515153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of uterine contraction with tocolytic agents (ritodrine). 2. Use in cases of threatened abortion, cervical incontinence and gynecologic surgery in pregnancy].
    Colombo PA; Pittino R; Pascalino MC; Quaranta S
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):431-40. PubMed ID: 7337350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment of threatened abortion with Partusisten (preparation Th 1165 A)].
    Dzioba A; Sward J; Gajewski A; Smulikowski A
    Wiad Lek; 1975 Jul; 28(14):1193-6. PubMed ID: 1162990
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 11. Medroxyprogesterone acetate therapy in early pregnancy has no apparent fetal effects.
    Yovich JL; Turner SR; Draper R
    Teratology; 1988 Aug; 38(2):135-44. PubMed ID: 3175947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aggressive management of imminent abortion in the second trimester of pregnancy due to cervix incompetence].
    Lema Cofré R; González Bruzzone P
    Rev Chil Obstet Ginecol; 1985; 50(5):403-6. PubMed ID: 3843288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of threatened early abortion (6th-16th week of pregnancy) of Th 1165a (Partusisten)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1976; 98(13):792-4. PubMed ID: 8935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential approach to the treatment of threatened abortion].
    Borisova IuF; Egorova EV; Kifer GI; Povolotskaia LI
    Sov Med; 1977 Sep; (9):100-3. PubMed ID: 563107
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 16. [On combined estro-progestogenic and antireactional treatment in threatened abortion].
    Goisis M; Oppo GT
    Minerva Ginecol; 1971 Jun; 23(11):547-52. PubMed ID: 5566453
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Threatened abortion. Development and treatment].
    Maretti M; Vitiello N; Lacreta O
    Matern Infanc (Sao Paulo); 1970; 29(1):71-8. PubMed ID: 5516901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current concepts in the management of abortion. IV. Results gained in the treatment of abortion using new progestational steroids].
    Alvarez-Bravo A; Vázquez E; González-Ramos M
    Gac Med Mex; 1968 Oct; 98(10):1275-87. PubMed ID: 5729387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.